|
schizophrenia |
100 |
|
depression |
99 |
|
humans |
90 |
|
female |
83 |
|
covid-19 |
82 |
|
mental health |
79 |
|
male |
76 |
|
adult |
75 |
|
hong kong |
75 |
|
chinese |
67 |
|
quality of life |
59 |
|
anxiety |
58 |
|
adolescent |
57 |
|
middle aged |
57 |
|
first-episode psychosis |
49 |
|
medical sciences |
48 |
|
psychosis |
48 |
|
aged |
47 |
|
risk factors |
47 |
|
interprofessional education |
44 |
|
negative symptoms |
44 |
|
youth mental health |
42 |
|
mindfulness |
41 |
|
follow-up studies |
40 |
|
randomized controlled trial |
38 |
|
stigma |
38 |
|
psychotic disorders |
37 |
|
resilience |
37 |
|
depressive symptoms |
36 |
|
china |
35 |
|
early intervention |
35 |
|
psychological distress |
33 |
|
older adults |
32 |
|
prevalence |
32 |
|
treatment outcome |
32 |
|
early psychosis |
30 |
|
evaluation |
30 |
|
hong kong - epidemiology |
30 |
|
intervention |
30 |
|
meta-analysis |
30 |
|
nasopharyngeal carcinoma |
30 |
|
time factors |
30 |
|
functioning |
29 |
|
psychiatry and neurology |
29 |
|
relapse |
29 |
|
cost-effectiveness |
28 |
|
partnership model |
28 |
|
predictors |
28 |
|
prognosis |
28 |
|
social interaction anxiety |
28 |
|
stress |
28 |
|
perceived stress |
27 |
|
recurrence |
27 |
|
adolescents |
26 |
|
mediation |
26 |
|
assessment |
25 |
|
physical activity |
25 |
|
post-traumatic stress disorder |
25 |
|
psychiatric status rating scales |
25 |
|
first episode |
24 |
|
systematic review |
24 |
|
age factors |
23 |
|
cancer |
23 |
|
first-episode schizophrenia |
23 |
|
palliative care |
23 |
|
spirituality |
23 |
|
duration of untreated psychosis |
22 |
|
epidemiology |
22 |
|
questionnaires |
22 |
|
rehabilitation |
22 |
|
remission |
22 |
|
violence |
22 |
|
asian continental ancestry group |
21 |
|
child |
21 |
|
cognitive impairment |
21 |
|
exercise |
21 |
|
outcome |
21 |
|
rumination |
21 |
|
social unrest |
21 |
|
suicide |
21 |
|
caregivers |
20 |
|
cognition |
20 |
|
pandemic |
20 |
|
dopamine |
19 |
|
insight |
19 |
|
psychopathology |
19 |
|
schizophrenic psychology |
19 |
|
suicidal ideation |
19 |
|
survival analysis |
19 |
|
antipsychotics |
18 |
|
executive function |
18 |
|
family caregiver |
18 |
|
intimate partner violence |
18 |
|
longitudinal |
18 |
|
prevention |
18 |
|
validation |
18 |
|
aged, 80 and over |
17 |
|
child, preschool |
17 |
|
recovery |
17 |
|
sex factors |
17 |
|
yoga |
17 |
|
adult learning principles |
16 |
|
age of onset |
16 |
|
child maltreatment |
16 |
|
child psychosocial problems |
16 |
|
collaborative practice |
16 |
|
combined modality therapy |
16 |
|
coronavirus |
16 |
|
culture |
16 |
|
delusional disorder |
16 |
|
employment |
16 |
|
functional outcome |
16 |
|
healthcare workers |
16 |
|
home confinement |
16 |
|
hospital policies |
16 |
|
latent class analysis |
16 |
|
mind-body intervention |
16 |
|
neoplasm staging |
16 |
|
psychological wellbeing |
16 |
|
relapse prevention |
16 |
|
school closure |
16 |
|
social support |
16 |
|
youth |
16 |
|
amotivation |
15 |
|
body-mind-spirit |
15 |
|
effectiveness |
15 |
|
elderly |
15 |
|
first-episode |
15 |
|
loneliness |
15 |
|
parkinson’s disease |
15 |
|
pregnancy |
15 |
|
prospective studies |
15 |
|
psychotic-like experiences |
15 |
|
qigong |
15 |
|
sleep disturbance |
15 |
|
survival rate |
15 |
|
avolition |
14 |
|
early diagnosis |
14 |
|
incidence |
14 |
|
infant |
14 |
|
medication adherence |
14 |
|
meditation |
14 |
|
psychometrics |
14 |
|
ptsd symptoms |
14 |
|
radiotherapy |
14 |
|
recurrent nasopharyngeal carcinoma |
14 |
|
reliability |
14 |
|
self-stigma |
14 |
|
cadaver |
13 |
|
chinese culture |
13 |
|
collaborative stepped care |
13 |
|
dementia |
13 |
|
mental health services |
13 |
|
mindfulness-based intervention |
13 |
|
mortality |
13 |
|
multivariate analysis |
13 |
|
peer support |
13 |
|
premorbid adjustment |
13 |
|
psychotic disorders - diagnosis |
13 |
|
rct |
13 |
|
review |
13 |
|
smoking cessation |
13 |
|
symptomatology |
13 |
|
treatment |
13 |
|
validation study |
13 |
|
adherence |
12 |
|
affect |
12 |
|
cognitive behavioral therapy |
12 |
|
cognitive behavioural therapy |
12 |
|
end-of-life care |
12 |
|
experience sampling method |
12 |
|
graft survival |
12 |
|
internalized stigma |
12 |
|
memory |
12 |
|
momentary positive affect |
12 |
|
pediatric liver transplantation |
12 |
|
psychotic symptoms |
12 |
|
qualitative research |
12 |
|
remission induction |
12 |
|
retrospective studies |
12 |
|
severity of illness index |
12 |
|
well-being |
12 |
|
cognitive function |
11 |
|
cortisol |
11 |
|
diminished expression |
11 |
|
expressive arts |
11 |
|
family caregivers |
11 |
|
gender |
11 |
|
gene expression regulation, neoplastic |
11 |
|
infertility |
11 |
|
intraoperative complications - epidemiology |
11 |
|
liver function tests |
11 |
|
liver transplantation - statistics & numerical data |
11 |
|
living donors |
11 |
|
long-term outcomes |
11 |
|
longitudinal follow-up |
11 |
|
maintenance treatment |
11 |
|
maternal age |
11 |
|
mindfulness training |
11 |
|
mri |
11 |
|
paternal age |
11 |
|
path analysis |
11 |
|
pattern glare |
11 |
|
perceptual distortions |
11 |
|
processing speed |
11 |
|
prospective follow-up |
11 |
|
psychoeducation |
11 |
|
psychosocial intervention |
11 |
|
randomized controlled trial (rct) |
11 |
|
risk factor |
11 |
|
salivary cortisol |
11 |
|
self-reference |
11 |
|
stroke |
11 |
|
survival |
11 |
|
virtual reality |
11 |
|
young people |
11 |
|
activities of daily living |
10 |
|
adaptation, psychological |
10 |
|
antipsychotic |
10 |
|
antipsychotic agents - therapeutic use |
10 |
|
attitude |
10 |
|
attitude to health |
10 |
|
awareness |
10 |
|
burnout |
10 |
|
caregiving |
10 |
|
cognitive functions |
10 |
|
community |
10 |
|
community-based intervention |
10 |
|
coping |
10 |
|
disease-free survival |
10 |
|
disengagement |
10 |
|
double blind |
10 |
|
drug therapy, combination |
10 |
|
earthquake |
10 |
|
f-dopa |
10 |
|
family |
10 |
|
head and neck cancer |
10 |
|
health economics |
10 |
|
health service research |
10 |
|
hospitalization |
10 |
|
human |
10 |
|
immunosuppressive agents - therapeutic use |
10 |
|
liver diseases - surgery |
10 |
|
liver transplantation - methods |
10 |
|
liver transplantation - methods - statistics and numerical data |
10 |
|
living donors - supply and distribution |
10 |
|
lung cancer |
10 |
|
magnetic resonance imaging |
10 |
|
maintenance |
10 |
|
mental illness |
10 |
|
neck dissection |
10 |
|
oncology |
10 |
|
personality |
10 |
|
polymerase chain reaction |
10 |
|
positron emission tomography |
10 |
|
postoperative complications - epidemiology |
10 |
|
prospective study |
10 |
|
psychological well-being |
10 |
|
psychosocial |
10 |
|
ptsd |
10 |
|
public stigma |
10 |
|
risk assessment |
10 |
|
scarce deceased donors |
10 |
|
sex difference |
10 |
|
sleep |
10 |
|
stereotyping |
10 |
|
stress/burden |
10 |
|
striatal dopamine capacity synthesis |
10 |
|
tissue donors - supply and distribution |
10 |
|
traumatic events |
10 |
|
treatment adherence |
10 |
|
validity |
10 |
|
workplace |
10 |
|
young adult |
10 |
|
youth-friendly |
10 |
|
adults |
9 |
|
bipolar disorder |
9 |
|
cancer patients |
9 |
|
case-control studies |
9 |
|
caudate |
9 |
|
chi-square distribution |
9 |
|
children |
9 |
|
cross-sectional studies |
9 |
|
delusions |
9 |
|
dose-response relationship, drug |
9 |
|
early medical intervention - methods - trends |
9 |
|
epidemiological youth |
9 |
|
esm |
9 |
|
factor analysis |
9 |
|
genome-wide association study |
9 |
|
hallucination |
9 |
|
health education - methods |
9 |
|
help-seeking |
9 |
|
hospitals, university |
9 |
|
ideas of reference |
9 |
|
immunohistochemistry |
9 |
|
interleukin-6 |
9 |
|
ivf |
9 |
|
life events |
9 |
|
liver diseases - epidemiology |
9 |
|
liver failure - surgery |
9 |
|
longitudinal study |
9 |
|
mediator |
9 |
|
mental disorders |
9 |
|
mental health services - trends |
9 |
|
micrornas - genetics |
9 |
|
momentary assessment |
9 |
|
motivational deficits |
9 |
|
neuropsychological tests |
9 |
|
omicron |
9 |
|
parkinson's disease |
9 |
|
prediction |
9 |
|
program development |
9 |
|
psychotic disorders - therapy |
9 |
|
sleep quality |
9 |
|
smartphone overuse |
9 |
|
social context |
9 |
|
social functioning |
9 |
|
squamous cell carcinoma |
9 |
|
stents |
9 |
|
structural equation modeling |
9 |
|
telomerase |
9 |
|
abused women |
8 |
|
aerobic exercises |
8 |
|
aggressive behavior |
8 |
|
analysis of variance |
8 |
|
asia |
8 |
|
bereavement |
8 |
|
biliary atresia |
8 |
|
biliary atresia - complications - surgery |
8 |
|
body weight |
8 |
|
brain |
8 |
|
brain - ultrastructure |
8 |
|
breast cancer |
8 |
|
chemicals and cas registry numbers |
8 |
|
child sexual abuse |
8 |
|
chinese women |
8 |
|
cluster analysis |
8 |
|
cognition disorders - etiology |
8 |
|
complications of liver transplantation |
8 |
|
corpus striatum |
8 |
|
craniofacial resection |
8 |
|
cyclosporine - therapeutic use |
8 |
|
delusions - diagnosis |
8 |
|
delusions - etiology |
8 |
|
diffusion tensor imaging |
8 |
|
discontinuation |
8 |
|
dose-dependent effect |
8 |
|
double-blind method |
8 |
|
drug-naive |
8 |
|
elder abuse |
8 |
|
enzyme-linked immunosorbent assay |
8 |
|
eye-gaze perception |
8 |
|
fractional anisotropy |
8 |
|
growth mixture modeling |
8 |
|
interview, psychological - methods |
8 |
|
intimate partner violence (ipv) |
8 |
|
liver diseases - etiology - surgery |
8 |
|
liver transplantation |
8 |
|
liver transplantation - adverse effects - statistics & numerical data |
8 |
|
liver transplantation - contraindications - methods - mortality - statistics & numerical data |
8 |
|
liver transplantation - mortality |
8 |
|
living donor liver transplant |
8 |
|
living-related liver transplantation |
8 |
|
logistic models |
8 |
|
long-term outcome |
8 |
|
mass screening |
8 |
|
mass screening - methods |
8 |
|
measurement invariance |
8 |
|
media |
8 |
|
mentalization |
8 |
|
migration |
8 |
|
mild cognitive impairment |
8 |
|
mind-body exercises |
8 |
|
mode of onset |
8 |
|
organ size |
8 |
|
panss |
8 |
|
pediatric liver transplant |
8 |
|
persistent psychotic experience |
8 |
|
pharyngectomy |
8 |
|
poor sleep |
8 |
|
portoenterostomy, hepatic |
8 |
|
postoperative care |
8 |
|
postoperative complications |
8 |
|
postoperative complications - classification - epidemiology |
8 |
|
postoperative complications - prevention & control |
8 |
|
predictive factors |
8 |
|
predictive value of tests |
8 |
|
psychotherapy |
8 |
|
psychotic disorder |
8 |
|
psychotic disorders - complications |
8 |
|
qualitative |
8 |
|
raclopride |
8 |
|
reduced-size liver transplant |
8 |
|
reduced-size liver transplantation |
8 |
|
reoperation |
8 |
|
reproducibility of results |
8 |
|
rural china |
8 |
|
salvage therapy |
8 |
|
scale validation |
8 |
|
schizophrenia - complications |
8 |
|
schizophrenia - diagnosis |
8 |
|
schizophrenia - pathology |
8 |
|
self |
8 |
|
self-discrepancy |
8 |
|
semantic |
8 |
|
sex differences |
8 |
|
sex knowledge |
8 |
|
sexual risk behaviors |
8 |
|
sexually transmitted infections |
8 |
|
temporal lobe - ultrastructure |
8 |
|
tissue donors |
8 |
|
tissue donors - statistics & numerical data |
8 |
|
tongue |
8 |
|
trauma exposure |
8 |
|
work engagement |
8 |
|
youth sexuality |
8 |
|
amino acid substitution - genetics |
7 |
|
anastomosis, roux-en-y |
7 |
|
anastomosis, surgical - methods |
7 |
|
animals |
7 |
|
anti-stigma campaigns |
7 |
|
antipsychotic agents - administration and dosage |
7 |
|
asian continental ancestry group - genetics |
7 |
|
base sequence |
7 |
|
behavioral symptoms - etiology - psychology - therapy |
7 |
|
big five |
7 |
|
bile duct diseases - etiology |
7 |
|
bile ducts - blood supply - surgery |
7 |
|
bilirubin - blood |
7 |
|
biopsy |
7 |
|
brachytherapy |
7 |
|
brief intervention |
7 |
|
cadaveric transplantation |
7 |
|
caregiver burden |
7 |
|
cell growth processes - genetics |
7 |
|
child abuse and neglect |
7 |
|
chinese context |
7 |
|
clozapine |
7 |
|
cognitive structure |
7 |
|
content-dependent process |
7 |
|
convergent validity |
7 |
|
course |
7 |
|
covid-19 pandemic |
7 |
|
dementia and cognitive disorders |
7 |
|
depressive mood |
7 |
|
development |
7 |
|
digitalization |
7 |
|
disease progression |
7 |
|
duration of untreated psychosis (dup) |
7 |
|
early detection |
7 |
|
effort-cost computation |
7 |
|
endophenotype |
7 |
|
epigenetic regulation |
7 |
|
euclidean distance analysis |
7 |
|
executive function - physiology |
7 |
|
extended early intervention |
7 |
|
first episode psychosis |
7 |
|
first-episode schizophrenia spectrum disorder |
7 |
|
functional remission |
7 |
|
gender differences |
7 |
|
genotype |
7 |
|
graft rejection |
7 |
|
health literacy |
7 |
|
health service accessibility |
7 |
|
health status |
7 |
|
help‐seeking |
7 |
|
hepatic artery - surgery |
7 |
|
hepatic encephalopathy - surgery |
7 |
|
hepatitis - surgery |
7 |
|
hepatitis b - complications |
7 |
|
hepatitis b virus - genetics |
7 |
|
herpesvirus 4, human - genetics |
7 |
|
histocompatibility |
7 |
|
identity |
7 |
|
illness disclosure |
7 |
|
indirect effects |
7 |
|
informed consent |
7 |
|
integrative body-mind-spirit (ibms) |
7 |
|
knowledge |
7 |
|
language |
7 |
|
late-onset psychosis |
7 |
|
latent class growth analysis |
7 |
|
let-7 |
7 |
|
liver diseases - congenital - mortality - surgery |
7 |
|
liver diseases - epidemiology - surgery |
7 |
|
liver transplantation - adverse effects - methods - mortality |
7 |
|
liver transplantation - adverse effects - methods - pathology - statistics & numerical data |
7 |
|
liver transplantation - methods - physiology |
7 |
|
living donors - classification |
7 |
|
long-term follow-up |
7 |
|
longitudinal course |
7 |
|
longitudinal studies |
7 |
|
major depressive disorder |
7 |
|
marriage |
7 |
|
meaning in life |
7 |
|
medication-naïve |
7 |
|
mental health assessments |
7 |
|
mental health literacy |
7 |
|
mental health services - organization and administration |
7 |
|
micrornas |
7 |
|
microsurgery |
7 |
|
microvascular anastomosis |
7 |
|
motivational impairment |
7 |
|
mutations |
7 |
|
nasopharyngeal neoplasms - genetics - metabolism - pathology |
7 |
|
network analysis |
7 |
|
neuregulin 1 |
7 |
|
neuregulin-1 - genetics |
7 |
|
neurobiology |
7 |
|
neuropsychology |
7 |
|
nomenclature |
7 |
|
nucleocapsid - analysis |
7 |
|
olt |
7 |
|
outcome assessment (health care) |
7 |
|
overcontrolled |
7 |
|
parenting |
7 |
|
partner violence |
7 |
|
pathways |
7 |
|
patient selection |
7 |
|
persistent primary negative symptoms |
7 |
|
personal attributes |
7 |
|
pilot |
7 |
|
polymorphism, single nucleotide - genetics |
7 |
|
postoperative complications - prevention & control - surgery |
7 |
|
preoperative care |
7 |
|
prodrome |
7 |
|
prognostic factors |
7 |
|
proliferation |
7 |
|
proto-oncogene proteins c-myc - biosynthesis - genetics |
7 |
|
psychiatric symptomatology |
7 |
|
psychotherapy - methods |
7 |
|
psychotic disorders - diagnosis - drug therapy - therapy |
7 |
|
psychotic disorders - diagnosis - psychology |
7 |
|
psychotic disorders - drug therapy |
7 |
|
ptsd symptoms, women mental health |
7 |
|
real-world functioning |
7 |
|
registries |
7 |
|
rehospitalization |
7 |
|
resilient |
7 |
|
risk taking |
7 |
|
rna, messenger - metabolism |
7 |
|
salvage surgery |
7 |
|
sars virus - chemistry |
7 |
|
schizophrenia - complications - diagnosis - epidemiology - therapy |
7 |
|
schizophrenia - genetics |
7 |
|
selective neck dissection |
7 |
|
self-differentiation |
7 |
|
sepsis - prevention & control |
7 |
|
severe acute respiratory syndrome - diagnosis |
7 |
|
sex characteristics |
7 |
|
six elements |
7 |
|
smartphone addiction |
7 |
|
social work education |
7 |
|
sociodemographic correlates |
7 |
|
stability |
7 |
|
stagnation |
7 |
|
stigmatization |
7 |
|
stressful life event |
7 |
|
suicide attempt |
7 |
|
suicide, attempted - psychology |
7 |
|
tai chi |
7 |
|
terminology as topic |
7 |
|
thrombosis - prevention & control |
7 |
|
trauma |
7 |
|
treatment delay |
7 |
|
undercontrolled |
7 |
|
unemployment |
7 |
|
v266l |
7 |
|
vascular surgical procedures - methods |
7 |
|
wenchuan earthquake |
7 |
|
woman smoker |
7 |
|
women |
7 |
|
1-week nicotine replacement therapy sampling |
6 |
|
actor-partner interdependence model |
6 |
|
acute kidney injury - surgery |
6 |
|
adiponectin |
6 |
|
affective psychoses |
6 |
|
anti-psychotics |
6 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
6 |
|
antipsychotic agents - pharmacology - therapeutic use |
6 |
|
anxiety disorders |
6 |
|
anxiety symptoms |
6 |
|
app |
6 |
|
arhgap4 |
6 |
|
art therapy |
6 |
|
at‐risk mental state |
6 |
|
balloon analogue risk task |
6 |
|
blinking |
6 |
|
blood loss, surgical |
6 |
|
brain - drug effects - metabolism - pathology |
6 |
|
caregiving burden |
6 |
|
categorization |
6 |
|
category fluency |
6 |
|
cell differentiation |
6 |
|
cerebrovascular disease |
6 |
|
cessation service use at clinics |
6 |
|
child abuse |
6 |
|
chinese zodiac signs |
6 |
|
chizophrenia |
6 |
|
chronic illness |
6 |
|
clinical high‐risk |
6 |
|
clinical predictors |
6 |
|
clinical trial |
6 |
|
clozapine-resistant schizophrenia |
6 |
|
cognitive clusters |
6 |
|
cognitive flexibility |
6 |
|
cognitive heterogeneity |
6 |
|
cognitive insights |
6 |
|
community smoker |
6 |
|
communityolder |
6 |
|
comparative effectiveness |
6 |
|
compliance |
6 |
|
complications |
6 |
|
concepts |
6 |
|
cultural sensitivity |
6 |
|
curcumin |
6 |
|
dating violence |
6 |
|
decision making |
6 |
|
delivery of health care - standards |
6 |
|
demography |
6 |
|
depressive symptons |
6 |
|
dibenzothiazepines - therapeutic use |
6 |
|
digit symbol test |
6 |
|
digital technologies |
6 |
|
dna methylation |
6 |
|
drug naïve |
6 |
|
e-cadherin |
6 |
|
early intervention service |
6 |
|
early medical intervention - standards |
6 |
|
effort allocation |
6 |
|
effort discounting |
6 |
|
effort-based decision-making |
6 |
|
emergency medical services |
6 |
|
emotional distress |
6 |
|
epidemiological study |
6 |
|
ethnic minority |
6 |
|
family caregiving |
6 |
|
fitmind |
6 |
|
fractionation |
6 |
|
genetics |
6 |
|
gerontology and geriatrics |
6 |
|
global functioning |
6 |
|
growth |
6 |
|
guideline |
6 |
|
han chinese |
6 |
|
hardiness |
6 |
|
health surveys |
6 |
|
health-related quality of life |
6 |
|
history |
6 |
|
hnscc |
6 |
|
holistic health |
6 |
|
holistic well-being |
6 |
|
hrqol |
6 |
|
illness attributional belief |
6 |
|
immersive |
6 |
|
in-law conflict |
6 |
|
income instability |
6 |
|
instant messaging |
6 |
|
intellectual disability |
6 |
|
internal feed-forward |
6 |
|
interpersonal relations |
6 |
|
intervention research |
6 |
|
interview, psychological |
6 |
|
job loss |
6 |
|
labelling |
6 |
|
laryngopharyngeal reflux |
6 |
|
length of stay |
6 |
|
letter |
6 |
|
life satisfaction |
6 |
|
lifetime prevalence |
6 |
|
liver - pathology - ultrasonography |
6 |
|
liver transplantation - adverse effects |
6 |
|
long-term trajectories |
6 |
|
longitudinal negative symptoms |
6 |
|
lungquality of life |
6 |
|
mecp2 |
6 |
|
mental disorders / epidemiology |
6 |
|
mental health services - standards |
6 |
|
meta analysis |
6 |
|
metabolic syndrome |
6 |
|
methodology |
6 |
|
mhealth |
6 |
|
mice |
6 |
|
mobile truck |
6 |
|
molecular sequence data |
6 |
|
multiple sclerosis |
6 |
|
nasopharyngeal neoplasms - genetics |
6 |
|
naturalistic |
6 |
|
negative treatment attitude |
6 |
|
network meta-analysis |
6 |
|
neurocognition |
6 |
|
neuroleptic agent |
6 |
|
neuronal plasticity - drug effects |
6 |
|
outcomes |
6 |
|
paranoid schizophrenia |
6 |
|
passivity experiences |
6 |
|
perceived social support |
6 |
|
perinatal depression |
6 |
|
pilot trial |
6 |
|
polymerase chain reaction - methods |
6 |
|
polypharmacy |
6 |
|
population surveys |
6 |
|
post-traumatic growth |
6 |
|
predictive validity |
6 |
|
primary negative symptoms |
6 |
|
priority journal |
6 |
|
problem solving |
6 |
|
problem-based learning |
6 |
|
process outcome |
6 |
|
psychiatric comorbidity |
6 |
|
psychiatric disorders |
6 |
|
psycho-oncology |
6 |
|
psychological health |
6 |
|
psychological symptoms |
6 |
|
psychometric validation |
6 |
|
psychophysiology |
6 |
|
psychosocial functioning |
6 |
|
public health |
6 |
|
qualitative systematic review |
6 |
|
quit attempt |
6 |
|
radiotherapy dosage |
6 |
|
recommendation |
6 |
|
renbp |
6 |
|
research |
6 |
|
risk aversion |
6 |
|
risky–gains task |
6 |
|
schizophrenia - drug therapy - physiopathology |
6 |
|
schizophrenia-spectrum disorder |
6 |
|
selective attention |
6 |
|
self-monitoring |
6 |
|
smartphone |
6 |
|
smoking |
6 |
|
stressful life events |
6 |
|
stroke rehabilitation |
6 |
|
subjective quality of life |
6 |
|
suicidal behavior |
6 |
|
suicide-statistics-and-numerical-data |
6 |
|
switching |
6 |
|
symptomatic remission |
6 |
|
temperature |
6 |
|
tobacco |
6 |
|
tors |
6 |
|
transformation |
6 |
|
treatment failure |
6 |
|
treatment resistant schizophrenia |
6 |
|
treatment-resistant schizophrenia |
6 |
|
ultra-high risk |
6 |
|
vocational outcome |
6 |
|
voxel-based morphometry |
6 |
|
vr |
6 |
|
weather |
6 |
|
web-based |
6 |
|
whatsapp |
6 |
|
10-year follow-up |
5 |
|
10-year outcomes |
5 |
|
1st episode |
5 |
|
abuse |
5 |
|
acculturation |
5 |
|
acute disease |
5 |
|
adenine - analogs & derivatives - therapeutic use |
5 |
|
adolescence |
5 |
|
adolescent onset |
5 |
|
adult onset |
5 |
|
adult sexual victimization |
5 |
|
affiliate stigma |
5 |
|
affliction |
5 |
|
alcohol use disorders |
5 |
|
alogia |
5 |
|
anhedonia |
5 |
|
antineoplastic agent |
5 |
|
antiviral agents - therapeutic use |
5 |
|
asian network for early psychosis |
5 |
|
asociality |
5 |
|
at-risk mental state |
5 |
|
attention |
5 |
|
auditory cortex |
5 |
|
auditory hallucination |
5 |
|
azathioprine - therapeutic use |
5 |
|
baduanjin qigong exercise |
5 |
|
behavior |
5 |
|
bereavers |
5 |
|
bi-factor model |
5 |
|
biomarker |
5 |
|
biopsy, needle |
5 |
|
blunted affect |
5 |
|
borderline personality traits |
5 |
|
brain size |
5 |
|
brain synchronization |
5 |
|
breathing exercises |
5 |
|
cancer chemotherapy |
5 |
|
cancer radiotherapy |
5 |
|
carcinoma - blood - diagnosis - genetics |
5 |
|
carcinoma, hepatocellular - complications - surgery |
5 |
|
carcinoma, squamous cell - mortality - pathology - surgery - therapy |
5 |
|
caregiver |
5 |
|
caregivers’ distress |
5 |
|
case management |
5 |
|
cell line, tumor |
5 |
|
ces-d |
5 |
|
childhood emotional abuse |
5 |
|
chinese medicine |
5 |
|
chinese population |
5 |
|
chronic fatigue syndrome (cfs) |
5 |
|
chronic illness care |
5 |
|
chronic schizophrenia |
5 |
|
clinical high-risk |
5 |
|
clinical trials |
5 |
|
clinical trials as topic |
5 |
|
cognition disorders - psychology |
5 |
|
cohort studies |
5 |
|
colorectal cancer |
5 |
|
community mental health |
5 |
|
community mental health service |
5 |
|
community mental health services |
5 |
|
community mental health services - organization and administration - utilization |
5 |
|
contact |
5 |
|
cortical thickness (brain) |
5 |
|
counseling |
5 |
|
cytokines - blood - genetics - metabolism |
5 |
|
dangerous |
5 |
|
death anxiety |
5 |
|
depression & mood disorders |
5 |
|
diagnosis |
5 |
|
diagnostic specificity |
5 |
|
discrimination |
5 |
|
disease severity |
5 |
|
dna - metabolism |
5 |
|
dna, viral - metabolism |
5 |
|
double-blind |
5 |
|
drug knowledge |
5 |
|
early medical intervention |
5 |
|
eastern |
5 |
|
ebv |
5 |
|
eeg |
5 |
|
ehealth |
5 |
|
embryo research - legislation & jurisprudence |
5 |
|
emotional suppression |
5 |
|
empathy |
5 |
|
endoscopy |
5 |
|
equanimity |
5 |
|
express emotion |
5 |
|
face concern |
5 |
|
factor structure |
5 |
|
family - psychology |
5 |
|
family characteristics |
5 |
|
family therapy |
5 |
|
family violence |
5 |
|
females |
5 |
|
financial deprivation |
5 |
|
first psychosis |
5 |
|
first-episode mania |
5 |
|
firstepisode psychosis |
5 |
|
first‐episode psychosis |
5 |
|
fmri |
5 |
|
follow-up study |
5 |
|
formal thought disorder |
5 |
|
free jejunum |
5 |
|
gad-7 |
5 |
|
gender effect |
5 |
|
general factor |
5 |
|
general self-efficacy |
5 |
|
genetic high-risk |
5 |
|
glucose supplement |
5 |
|
grommet |
5 |
|
group psychotherapy |
5 |
|
group-learning |
5 |
|
gut microbiome |
5 |
|
handgrip |
5 |
|
health-care professionals' attitude |
5 |
|
hepatectomy |
5 |
|
hepatectomy - methods |
5 |
|
hepatitis b, chronic - complications |
5 |
|
high-entropy music |
5 |
|
hiv |
5 |
|
hopelessness |
5 |
|
hospital mortality |
5 |
|
hyperscanning |
5 |
|
hypopharyngeal cancer |
5 |
|
impulse control |
5 |
|
indocyanine green |
5 |
|
intimate partner |
5 |
|
intimate terrorism |
5 |
|
knowledge about psychosis |
5 |
|
knowledge of medication |
5 |
|
language disorganization |
5 |
|
laryngeal neoplasms - radiotherapy - surgery |
5 |
|
laryngectomy - adverse effects |
5 |
|
laryngopharyngectomy |
5 |
|
learned irrelevance |
5 |
|
lifelong learning |
5 |
|
liver |
5 |
|
liver failure - etiology - surgery |
5 |
|
liver neoplasms - complications - surgery |
5 |
|
liver transplantation - immunology |
5 |
|
liver transplantation - immunology - methods - physiology |
5 |
|
liver transplantation - methods - mortality |
5 |
|
local recurrence |
5 |
|
lymph node metastasis |
5 |
|
mass media |
5 |
|
matrix metallopepetidase 10 |
5 |
|
maxillary swing nasopharyngectomy |
5 |
|
meaning reconstruction |
5 |
|
measurement |
5 |
|
media report violent |
5 |
|
mediators |
5 |
|
medication |
5 |
|
medication discontinuation |
5 |
|
medication knowledge |
5 |
|
mental health workers |
5 |
|
meta-aggregation |
5 |
|
metabolic screening |
5 |
|
middle ear ventilation - methods |
5 |
|
mind–body |
5 |
|
mobile-delivered intervention |
5 |
|
nasopharyngeal neoplasms - blood - diagnosis - genetics |
5 |
|
nasopharyngeal neoplasms - radiotherapy |
5 |
|
nasopharyngectomy |
5 |
|
neck dissection - methods |
5 |
|
nepali women |
5 |
|
neurocognitive impairment |
5 |
|
neurological examination abnormalities |
5 |
|
newspapers |
5 |
|
nf-κb |
5 |
|
nocturia |
5 |
|
nodal recurrence |
5 |
|
npc |
5 |
|
nuclear family |
5 |
|
obstetric/gynecology patients |
5 |
|
older people |
5 |
|
oncology psychology medical sciences |
5 |
|
optimism |
5 |
|
oral |
5 |
|
p16 |
5 |
|
patient demographics |
5 |
|
perceived public stigma |
5 |
|
phosphonic acids |
5 |
|
physical exercise |
5 |
|
physician-patient relations |
5 |
|
positive aspects of caregiving |
5 |
|
positive symptoms |
5 |
|
poverty |
5 |
|
preventive medicine |
5 |
|
primary prevention |
5 |
|
program |
5 |
|
programme evaluation |
5 |
|
promoter regions, genetic |
5 |
|
proton pump inhibitor |
5 |
|
psychiatric emergency admission |
5 |
|
psychiatry |
5 |
|
psychological abuse |
5 |
|
psychotic disorders - diagnosis - drug therapy - psychology |
5 |
|
psychotic-like experience |
5 |
|
public awareness |
5 |
|
quality of life - psychology |
5 |
|
rabeprazole |
5 |
|
randomised controlled trial |
5 |
|
randomized |
5 |
|
rasch model |
5 |
|
reconstruction |
5 |
|
relapse risk perception |
5 |
|
reproductive techniques, assisted - ethics - legislation & jurisprudence - standards |
5 |
|
reverse transcriptase polymerase chain reaction |
5 |
|
schizophrenia, first-episode |
5 |
|
schizophrenia-spectrum disorders |
5 |
|
school-based programme |
5 |
|
seasonality |
5 |
|
self-directed learning |
5 |
|
sensitivity and specificity |
5 |
|
severe mental illness |
5 |
|
sexual aggression |
5 |
|
situational couple violence |
5 |
|
skills workshop |
5 |
|
social connectedness |
5 |
|
social contact |
5 |
|
social stigma |
5 |
|
social work |
5 |
|
socioeconomic factors |
5 |
|
spouse abuse |
5 |
|
steroids - therapeutic use |
5 |
|
stigma of mental illness |
5 |
|
stigma reduction |
5 |
|
striato-thalamic volume |
5 |
|
students |
5 |
|
suicide - statistics & numerical data |
5 |
|
supportive-expressive therapy |
5 |
|
syntax |
5 |
|
tai-chi |
5 |
|
tobacco craving |
5 |
|
tongue cancer |
5 |
|
trait |
5 |
|
trial |
5 |
|
tumor suppressor proteins - blood - genetics - metabolism |
5 |
|
university students |
5 |
|
very brief intervention |
5 |
|
video |
5 |
|
waiting lists |
5 |
|
widowhood - psychology |
5 |
|
withdrawal symptom |
5 |
|
working memory |
5 |
